摘要/Abstract

以具有优秀药理活性的吡唑杂环为核心，连接1，3，5-三嗪杂环，引入三唑并噻二唑稠并环，设计合成了21个新型1，3，5-三嗪-1H-吡唑-三唑并噻二唑衍生物.应用IR，¹H NMR和HRMS等对21种新物质进行了结构表征.评价了21种新型目标产物对Cdc25B和PTP1B的抑制活性，结果发现，大部分目标分子显示了优良的抑制活性.在Cdc25B抑制活性测试中，14个目标分子抑制活性高于阳性参照物Na₃VO₄，有望成为潜在的Cdc25B抑制剂，在PTP1B抑制活性测试中，9个目标分子抑制活性优于阳性参照物齐墩果酸，有望成为潜在的PTP1B抑制剂.
关键词: 吡唑, 1,3,5-三嗪, 三唑并噻二唑, Cdc25B抑制剂, PTP1B抑制剂
Twenty-one novel 1, 3, 5-triazine-1H-pyrazole-triazolethiadiazole derivatives are designed and synthesized, in which the excellent pharmacological activitive pyrazole is used as key skeleton by connecting 1, 3, 5-triazine and introducing triazolothiadiazole. The structures of 21 target compounds are characterized by IR, ¹H NMR and HRMS. The inhibitory activities of 21 novel target products against Cdc25B and PTP1B are evaluated. As a result, most of the target compounds exhibit excellent inhibitory activities. In the Cdc25B inhibitory activity test, 14 target compounds have higher inhibitory activities than the positive reference sodium orthovanadate, and they are expected to be potential of Cdc25B inhibitors. In the PTP1B inhibitory activity test, 9 target compounds have better inhibitory activities than the control oleanolic acid, and they are expected to be potential of PTP1B inhibitors.
Key words: pyrazole, 1, 3, 5-triazine, triazolothiadiazole, Cdc25B inhibitor, PTP1B inhibitor


PDF全文下载地址:

点我下载PDF